-
AG-120 (Ivosidenib) in Mutant IDH1 Research
2026-08-24
AG-120, also called Ivosidenib, is an orally bioavailable inhibitor of mutant IDH1 that supports 2-hydroxyglutarate reduction and differentiation-focused AML research. Its strongest use is as a genotype-linked research tool, while resistance, IDH2 biology, and incomplete clinical translation define important limits.
-
MK-5108 (VX-689): AURKA Assay Design
2026-08-23
MK-5108, also known as VX-689, enables selective Aurora A inhibition for mechanism-led cancer research. This guide connects its biochemical profile with retinoblastoma biology, model selection, and more interpretable cell and xenograft assays.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-08-22
A 2026 study identified a novel FLCN nonsense variant and supplied functional and co-segregation evidence that reclassifies p.W376R as pathogenic in two Chinese Birt-Hogg-Dubé families. Its cell-based mRNA rescue experiments restored folliculin expression and normalized mTORC1 dysregulation, providing a preliminary framework for protein-replacement research rather than a clinical therapy.
-
AO/PI Double Staining Kit: Cell Viability Guide
2026-08-22
The AO/PI Double Staining Kit uses Acridine Orange Propidium Iodide staining to distinguish viable, apoptotic, and necrotic cells by fluorescence. Its dual-dye readout supports rapid cell viability assay workflows, but fluorescence categories require appropriate controls and should not be treated as a complete mechanistic diagnosis.
-
Metformin and AMPK in Vocal Fold Fibrosis
2026-08-21
The reference study combines a rabbit vocal fold injury model with TGF-β1-stimulated fibroblasts to show that metformin reduces collagen accumulation and myofibroblast-associated markers through AMPK signaling. Its value lies in connecting metabolic pathway modulation with vocal fold scar biology while also identifying dose, timing, functional recovery, and translational questions that require further study.
-
Cy3-dCTP for Direct Fluorescent DNA Labeling
2026-08-20
Cy3-dCTP enables direct enzymatic labeling of DNA and cDNA for PCR, Nick Translation, microarrays, blots, and in situ hybridization. This practical guide combines product-specific handling with a recent DNA-framework study to improve labeling consistency while separating validated workflows from forward-looking assay design.
-
Baicalin Methyl Ester and Intestinal Barrier Protection
2026-08-20
The 2024 reference study shows that baicalin methyl ester attenuates LPS-induced intestinal barrier injury in mice and MODE-K epithelial cells by regulating the P65/TNF-α/MLCK/ZO-1 axis. Its integrated in vivo, in vitro, molecular docking, and immunoprecipitation evidence provides a useful framework for studying cytokine-driven tight-junction disruption, while the acute pretreatment design limits direct clinical extrapolation.
-
Grazoprevir Hydrate: From Target to Assay
2026-08-19
Grazoprevir hydrate is a picomolar HCV NS3/4A protease inhibitor with a distinctive genotype-sensitive pharmacology. This assay-focused guide connects mechanism, translational evidence, pharmacokinetics, and practical experimental design.
-
Sildenafil Citrate: PDE5 Workflows for Vascular Research
2026-08-19
Sildenafil Citrate enables controlled interrogation of cGMP-dependent vascular signaling, from PDE5 activity and smooth muscle relaxation to ERK1/ERK2 phosphorylation in PASMCs. This workflow-focused guide also shows how proteoform-resolved native mass spectrometry can expose interaction differences that conventional cell assays may miss.
-
AO/PI Double Staining Kit: Practical QC Guide
2026-08-18
The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates viable, apoptotic, and membrane-compromised cells in one staining workflow. It is intended for in vitro cell analysis and should not be used as a standalone confirmation of cell-death pathways or for direct in vivo applications.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-18
FITC-Concanavalin A (ConA) Conjugate provides a direct fluorescent readout for accessible α-D-glucose and α-D-mannose moieties on glycoproteins and glycolipids. It is intended for cell surface carbohydrate detection, immunofluorescence staining, tissue labeling, and flow cytometry—not for general protein staining or non-carbohydrate targets.
-
Sildenafil Citrate: From cGMP Assay to Proteoform
2026-08-17
Sildenafil Citrate is a selective PDE5 research tool for connecting cGMP signaling with vascular phenotypes and proteoform-resolved drug interactions. This guide translates native-membrane findings into practical assay and interpretation decisions.
-
Caspase-3 Colorimetric Assay Kit in ER Stress
2026-08-17
The Caspase-3 Colorimetric Assay Kit converts DEVD-dependent protease activity into a practical apoptosis assay readout. This article shows how K2008 can complement ER-stress and intestinal macrophage studies without confusing caspase-3 activation with antibacterial function itself.
-
V5 Tags as Translational Assay Anchors
2026-08-16
The V5 Epitope Tag Peptide is more than a detection reagent: it is a defined molecular handle for connecting recombinant protein expression, immunoassay performance, and antibody-binding kinetics. This thought-leadership guide explains how translational researchers can use V5 tagging to build more reproducible and decision-ready protein workflows.
-
LRPPRC–Dasatinib Synergy in OXPHOS-Dependent Tumors
2026-08-15
A 2026 study identifies dasatinib as a synergistic partner for LRPPRC inhibition in cancer cells, revealing complementary suppression of nuclear- and mitochondrial genome-encoded oxidative phosphorylation genes. The findings provide a mechanistic framework for dual-genome OXPHOS targeting while highlighting the need for biomarker validation and in vivo assessment.